Filed Pursuant to Rule 424(b)(5)
Registration No. 333-262627
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 10, 2022)
![LOGO](https://capedge.com/proxy/424B5/0001193125-22-034670/g304578g05p01.jpg)
$250,000,000
PHILLIPS EDISON & COMPANY, INC.
Common Stock
On February 10, 2022, we entered into a sales agreement (as may be amended from time to time, the “sales agreement”) with Morgan Stanley & Co. LLC, BMO Capital Markets Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., CIBC World Markets Corp., Citigroup Global Markets Inc., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, Jefferies LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Regions Securities LLC and Wells Fargo Securities, LLC (collectively, the “Agents”), and, as applicable, the relevant Forward Purchasers (as defined below), relating to shares of our common stock, $0.01 par value per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus pursuant to a continuous offering program. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $250.0 million from time to time through the Agents as our sales agents, or, if applicable, as Forward Sellers (as defined below) or acting as principals.
Sales of shares of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made by means of ordinary brokers’ transactions on the Nasdaq Global Select Market (“Nasdaq”), in negotiated transactions or in transactions that are deemed to be “at-the-market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made to or through a market maker other than on an exchange, in block transactions or by any other method permitted by law, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, subject to certain minimum prices. The applicable Agent, as our sales agent or as a Forward Seller, as applicable, will use its commercially reasonable efforts consistent with its normal trading and sales practices to solicit offers to purchase shares of our common stock, under the terms and subject to the conditions set forth in the sales agreement. We may instruct any Agent, as our sales agent or as a Forward Seller, as applicable, not to sell shares of our common stock if the sales cannot be effected at or above the price designated by us in any placement notice. We or any of the Agents may suspend this offering at any time upon proper notice and subject to other conditions.
We also may sell shares of our common stock to each of the Agents, as principal for its own account, at a price to be agreed upon at the time of sale. If we sell shares of our common stock to any of the Agents, as principal, we will enter into a separate terms agreement with such Agent, and we will describe the terms agreement in a separate prospectus supplement or pricing supplement.
We will pay each of the Agents acting as our sales agent a commission that will not exceed, but may be lower than, 2.0% of the gross sales price per share of shares sold through it as our agent under the sales agreement. The compensation to each Agent acting as a Forward Seller will be a mutually agreed commission in the form of a reduction to the initial forward price under the related forward sale agreement that will not exceed, but may be lower than, 2.0% of the gross sales price of the borrowed shares sold through such Agent, acting as Forward Seller, during the applicable forward hedge selling period for such shares (which gross sales price will be adjusted for daily accruals based on a floating interest rate and specified amounts related to expected dividends on shares of our common stock if an “ex-dividend” date occurs during such forward hedge selling period). See “Plan of Distribution” and “Use of Proceeds” in this prospectus supplement.
None of the Agents, whether acting as our sales agent or as a Forward Seller, is required to sell any specific number or dollar amount of shares of our common stock but each will use its commercially reasonable efforts, as our sales agent or Forward Seller, as applicable, and subject to the terms of the sales agreement, to sell the shares offered as instructed by us (if acting as our sales agent) and all the shares borrowed by the relevant Forward Purchaser pursuant to the sales agreement (if acting as Forward Seller). The offering of shares of our common stock pursuant to the sales agreement will terminate upon the earlier of (1) the sale of all shares of our common stock subject to the sales agreement (including shares sold by us to or through the Agents and borrowed shares sold through the Agents, acting as Forward Sellers) or (2) termination of the sales agreement in accordance with its terms.
The sales agreement contemplates that, in addition to the issuance and sale by us of shares of our common stock to or through the Agents as our sales agents, we may enter into separate forward sale agreements (each, together with any related pricing supplement, a “forward sale agreement,” and, collectively, the “forward sale agreements”), with any of, respectively, Morgan Stanley & Co. LLC, Bank of America, N.A., Bank of Montreal, Canadian Imperial Bank of Commerce, Citibank, N.A. (or an affiliate thereof), Goldman Sachs & Co. LLC, Jefferies LLC, JPMorgan Chase Bank, National Association, KeyBanc Capital Markets Inc., Mizuho Markets Americas LLC, Regions Securities LLC and Wells Fargo Bank, National Association, or one of their respective affiliates (in such capacity, each, a “Forward Purchaser,” and, collectively, the “Forward Purchasers”). If we enter into a forward sale agreement with any Forward Purchaser, we expect that such Forward Purchaser, acting in accordance with the mutually accepted instructions related to such forward sale agreement, will attempt to borrow and sell, through the relevant Agent, acting as agent for such Forward Purchaser, shares of our common stock to hedge such Forward Purchaser’s exposure under such forward sale agreement. We refer to an Agent, when acting as sales agent for the relevant Forward Purchaser, as, individually, a “Forward Seller,” and, collectively, the “Forward Sellers.” Each Forward Purchaser will be either one of the Agents named in the first sentence of this paragraph or an affiliate of one of those Agents and, unless otherwise expressly stated or the context otherwise requires, references herein to the “related” or “relevant” Forward Purchaser mean, with respect to any Agent, the affiliate of such Agent that is acting as Forward Purchaser or, if applicable, such Agent acting in its capacity as Forward Purchaser. We will not initially receive any proceeds from any sale of shares of our common stock borrowed by a Forward Purchaser and sold through a Forward Seller.
We currently expect to fully physically settle each forward sale agreement, if any, with the relevant Forward Purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement. If we elect to cash settle any forward sale agreement, we may not receive any proceeds and we may owe cash to the relevant Forward Purchaser. If we elect to net share settle any forward sale agreement, we will not receive any proceeds, and we may owe shares of our common stock to the relevant Forward Purchaser. See “Plan of Distribution.”
Our common stock is listed on Nasdaq under the ticker symbol “PECO.” The last reported sale price of our common stock on Nasdaq on February 9, 2022 was $32.46 per share.
Our common stock is subject to certain restrictions on ownership and transfer, which are intended to assist us in preserving our qualification as a real estate investment trust (“REIT”) for federal income tax purposes, including an ownership limit of 9.8% of the outstanding shares of our common stock by value or number of shares, whichever is more restrictive. See “Description of Capital Stock—Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-2 of this prospectus supplement and the matters discussed in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | |
| | |
Morgan Stanley | | BMO Capital Markets | | BofA Securities |
| | |
BTIG | | Capital One Securities | | CIBC Capital Markets |
| | |
Citigroup | | Fifth Third Securities | | Goldman Sachs & Co. LLC |
| | |
Jefferies | | J.P. Morgan | | KeyBanc Capital Markets |
| | |
Mizuho Securities | | Regions Securities | | Wells Fargo Securities |
The date of this prospectus supplement is February 10, 2022.